Experimental CAR T therapy targets tumor's immune shield, not cancer cells directly

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...
Science Daily

Injection turns sleeping tumor immune cells into cancer fighters

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

Small number of 'highly plastic' cancer cells drive disease progression and treatment resistance

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

Active aldehydes drive T cell exhaustion in the tumor microenvironment, finds study

Cancer immunotherapy is a type of cancer treatment that harnesses the immune system to fight cancer cells. The treatment ...

Some Immune Systems Defeat Cancer. Could That Become a Drug?

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...
Frontiers

Metabolic crosstalk between tumors and regulatory immune cells

The tumor microenvironment (TME) is a metabolically dynamic niche where cancer cells and immune cells interact to influence tumor progression and immune ...
News-Medical.Net on MSN

Moffitt researchers develop a new way to predict how cancer cells evolve

Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole ...

Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread.